The mechanisms by which different physiological inputs alter VAPB-PTPIP51 binding to dynamically regulate ER-mitochondria signaling and how this is disrupted in neurodegenerative diseases are not properly understood. This evidence concerns the gene VAPB and neurodegenerative disease.